Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: A five-arm phase 2 study

Bohuslav Melichar, Antoine Adenis, A. Craig Lockhart, Jaafar Bennouna, E. Claire Dees, Omar Kayaleh, Radka Obermannova, Angela DeMichele, Petr Zatloukal, Bin Zhang, Claudio Dansky Ullmann, Claudia Schusterbauer

Research output: Contribution to journalArticlepeer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: A five-arm phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences